To determine whether the NKp44 expression in NK cells could have a clinical relevance in distinguishing STS patients, we performed a ROC analysis, which yielded an AUC of 0.94 (Figure 5B), highlighting its strong potential to distinguish STS patients from healthy donors. Here, NCR2 is linked to telomere syndrome.